Biomaterials Market growth is driven mainly by factors such as the increased funds grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine
The global biomaterials market size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393
Report Scope and Market Segmentation:
Report Metric | Details |
Market Size Available for Years | 2019–2026 |
Base Year Considered | 2020 |
Forecast Period | 2022–2026 |
Forecast Units | Value (USD Billion) |
Segments Covered | type, application and region |
Geographies Covered | North America, Europe, APAC, Latin America and Middle East Africa |
Companies Covered | BASF (Germany), Covestro AG (Germany), Celanese Corporation (Germany), Carpenter Technology (US), Olympus Terumo Biomaterials Corporation (Japan), Evonik Industries (Germany), Xylos Corporation (US), Victrex Plc (UK), Mitsubishi Chemical Holdings Corporation (Japan), GELITA AG (Germany), Corbion (Netherlands), Solvay (US), AB Specialty Silicones (US), CoorsTek (US), CeramTec GmbH (Germany), Royal DSM (Netherlands), The Lubrizol Corporation (US), Berkeley Advanced Biomaterials (US), Zeus Industrial Products, Inc. (US), Noble Biomaterials, Inc. (US), Dimension Inx (US), Artoss, Inc. (US), RDI Group (US), Riton Biomaterial Co., Ltd. (China), Cam Bioceramics (Netherlands) |
The metallic biomaterials segment accounted for the largest share of the type segment in the biomaterials market.
On the basis type of materials, the biomaterials market is broadly segmented into Metallic, Polymeric, Ceramic, and Natural biomaterials. Metallic biomaterials accounted for the largest share of the biomaterials market.
The cardiovascular application segment accounted for the largest share of the application segment in the biomaterials market.
Based on application, the biomaterials market is categorized into seven segments— cardiovascular, orthopedic, ophthalmology, neurological/central nervous system (CNS), dental, tissue engineering, wound healing, plastic surgery, and other applications.
The Asia Pacific region is the fastest-growing region of the biomaterials market
Asia Pacific region accounted for the fastest-growing region of the biomaterials market. It is also estimated to grow at the highest CAGR in the biomaterials market during the forecast period, this is mainly due to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.
BASF SE (Germany)
BASF is one of the leading players in the biomaterials market. The company focuses on various organic and inorganic means to enhance its presence in the market. The company also focuses on expanding its global production capacity and invests ~USD 450 million per year in optimizing its plants.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=393
